Mineral and bone disease - CKD 5D
M. Hecking, A. Kainz, B. Bielesz, M. Plischke et autres
Introduction and Aims: In Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) patients, most treatment decisions concerning vitamin D use, administration of calcimimetics and parathyroidectomy are guided by parathyroid hormone (PTH) levels. The quality of the PTH test has been judged of paramount …